101 related articles for article (PubMed ID: 45458)
1. Autologous stem cell reconstitution and the intensive therapy of resistant solid tumors in man.
Deisseroth A; Abrams R
Exp Hematol; 1979; 7 Suppl 5():347-50. PubMed ID: 45458
[No Abstract] [Full Text] [Related]
2. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of autologous transplantation with hematopoietic stem cells in leukemia and solid tumors].
Hinterberger W; Adler V; Bauer K; Haberhauer G; Habertheuer KH; Höniger S; Huber K; Kier P; Kittel E; Ruckser R
Wien Med Wochenschr; 1995; 145(2-3):34-40. PubMed ID: 7762250
[TBL] [Abstract][Full Text] [Related]
4. [Autologous bone marrow transplantation in solid tumors in adults: hopes and disappointment].
Laufer R; Ben Bassat Y; Meytes D
Harefuah; 1999 Nov; 137(9):399-404. PubMed ID: 11419045
[No Abstract] [Full Text] [Related]
5. The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms.
Deisseroth A; Abrams RA
Cancer Treat Rep; 1979 Mar; 63(3):461-71. PubMed ID: 371800
[No Abstract] [Full Text] [Related]
6. [Technical aspects of autologous bone marrow transplantation].
Handgretinger R; Klingebiel T; Niethammer D
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
[TBL] [Abstract][Full Text] [Related]
7. Autologous stem cell transplant: an overview.
Jassak PF; Riley MB
Cancer Pract; 1994; 2(2):141-5. PubMed ID: 7914454
[TBL] [Abstract][Full Text] [Related]
8. The combination of stem cell transplantation and immunotherapy: future potential.
Talmadge JE
In Vivo; 1994; 8(5):675-90. PubMed ID: 7727713
[TBL] [Abstract][Full Text] [Related]
9. [Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor].
Endo M; Tanosaki R
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1762-70. PubMed ID: 7574807
[TBL] [Abstract][Full Text] [Related]
10. Autologous hematopoietic stem cell transplantation for pediatric solid tumors.
Hale GA
Expert Rev Anticancer Ther; 2005 Oct; 5(5):835-46. PubMed ID: 16221053
[TBL] [Abstract][Full Text] [Related]
11. Is our current strategy in manipulating hemopoiesis in autologous transplantation correct?
To LB
Stem Cells; 1993 Jul; 11(4):283-9. PubMed ID: 8104615
[TBL] [Abstract][Full Text] [Related]
12. The use of autologous transplantation in the treatment of malignant disorders.
Territo M
J Rheumatol Suppl; 1997 May; 48():36-40. PubMed ID: 9150116
[TBL] [Abstract][Full Text] [Related]
13. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
[TBL] [Abstract][Full Text] [Related]
14. High dose therapy and autologous hematopoietic stem cell transplantation in poor risk solid tumors of childhood.
Dallorso S; Manzitti C; Morreale G; Faraci M
Haematologica; 2000 Nov; 85(11 Suppl):66-70. PubMed ID: 11268328
[TBL] [Abstract][Full Text] [Related]
15. [Autologous blood-derived stem cell transplantation in the treatment of hematopoietic malignant diseases (Part II)].
Tarach JS; Nowakowski A
Acta Haematol Pol; 1992; 23(4):221-7. PubMed ID: 1363454
[TBL] [Abstract][Full Text] [Related]
16. [From bone marrow transplantation to blood stem cell transplantation. Experiences from the first 100 autologous stem cell transplantation in Turku].
Remes K; Rajamäki A; Grenman S; Itälä M; Kauppila M; Nikoskelainen J; Pelliniemi TT; Ristamäki R; Salmi TT; Salmi T; Salminen E; Vanharanta R; Toivanen A
Duodecim; 1997; 113(3):219-28. PubMed ID: 11370030
[No Abstract] [Full Text] [Related]
17. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J; Baldomero H
Bone Marrow Transplant; 1997 Mar; 19(5):407-19. PubMed ID: 9052905
[TBL] [Abstract][Full Text] [Related]
18. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
[TBL] [Abstract][Full Text] [Related]
19. Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation.
Wu A; Mazumder A; Martuza RL; Liu X; Thein M; Meehan KR; Rabkin SD
Cancer Res; 2001 Apr; 61(7):3009-15. PubMed ID: 11306480
[TBL] [Abstract][Full Text] [Related]
20. [Stem cells in hematology and oncology].
Goldschmidt H; Egerer G; Fruehauf S; Ho AD
Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
